Abstract：Objective: To investigate the effect of immune cells and serum level of clinical effect in patients with Thymopeptide Enteric Injection adjuvant treatment of diabetes complicated with pulmonary tuberculosis. Methods: 98 cases of diabetic patients with tuberculosis infection in our hospital from June 2014 to June 2016, diagnosed by T-spot TB in, according to the principle of voluntary patients were divided into the control group and the control group with conventional therapy combined with thymosin adjuvant therapy, immune cell level contrast effect, the treatment group of two patients with tuberculosis in serum. Results:In the observation group, the duration of intensive treatment and the end of treatment were 37 and 42 cases, respectively. There were 36 cases and 41 cases of negative culture. There was no difference between the control group and the control group, P>0.05. The level of serum immune cells in patients with different types of contrast, found that the normal serum level of Treg cells was 1.3±0.6, significantly lower than those in patients with diabetes and diabetes combined with pulmonary tuberculosis, and the level of Th17 cells was 3.5±1.2, significantly higher than that in patients with diabetes and diabetes combined with pulmonary tuberculosis was significantly different, There was no difference in the level of Treg cell nuclear Th17 cells in the two groups before treatment, which was comparable. There was no difference in the incidence of symptoms between the two groups after treatment. After treatment, the disappearance rate of fatigue, night sweats, loss of appetite, cough and sputum in the observation group were 88.89%, 87.10%, 86.36%, 75%, 88.89%, which was significantly higher than that in the control group, with significant difference. Conclusion: While strengthening the anti-tuberculosis treatment, thymosin injection can improve the immune function of patients, help to improve the T cell subsets and promote the relief of clinical symptoms, which is worthy of clinical promotion and application.
匡剑韧. 胸腺肽辅助治疗对糖尿病合并肺结核患者治疗效果及血清中免疫细胞水平的影响[J]. 河北医学, 2018, 24(4): 545-547.
KUANG Jianren. Effect of Thymosin Adjuvant Therapy on the Treatment Effect of Diabetic Patients with Pulmonary Tuberculosis and the Effect of Serum Immune Cell Level. HeBei Med, 2018, 24(4): 545-547.
2018, Vol. 24 
冀公网安备13080202000677号